Assessment of a carcinogenic risk for treatment of Graves' ophthalmopathy in dependence on age and irradiation geometry

article





Broerse, J.J.

Snijders-Keilholz, A.

Jansen, J.Th.M.

Zoetelief, J.

Klein, C.

Seegenschmiedt, M.H.
In view of the probable carcinogenic risk due to the irradiation of Graves' ophthalmopathy in young patients the effective dose was assessed for two geometries. Adjusting the field to the conical outline of the orbit resulted in appreciable reduction in dose to uninvolved areas such as brain and bone marrow. In Leiden and in Essen the initial target dose was 20 Gy in 10 fractions of 2 Gy. Since 1996 the target dose in Essen was lowered to 10 fractions of 1.6 Gy with equal positive results. The combined effect of field optimization and 20% reduction in target dose has lowered the effective dose from 65 to 34 mSv. The attributable lifetime risk for fatal malignancies of 0.3% as a population average will be considerably reduced when the exposure occurs at older age.
Topics




















Carcinogenic riskGraves' ophthalmopathyAdultAge FactorsBone MarrowBrainDose FractionationEyeFemaleGraves DiseaseHumansMaleMonte Carlo MethodNeoplasms, Radiation-InducedNeoplasms, Second PrimaryOrbitPatient Care PlanningRadiotherapy DosageRisk AssessmentRisk FactorsStochastic Processes
TNO Identifier
235278
Repository link
https://resolver.tno.nl/uuid:990eb4d7-32ae-4bc0-88e4-ba0581238e2c
ISSN
01678140
Source
Radiotherapy and Oncology, 53(3), pp. 205-208.
Pages
205-208
Files
To receive the publication files, please send an e-mail request to TNO Repository.